Login to Your Account

Financings Roundup

Cempra Closes $46M Series C for Trials of Two Antibiotics

By Trista Morrison

Friday, May 15, 2009
Cempra Pharmaceuticals Inc. raised $46 million in a Series C financing to continue clinical trials with the two antibiotic programs it licensed three years ago from Optimer Pharmaceuticals Inc. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription